kyrgidis, athanassios printza, athanasia vitkos, evangelos lallas, konstantinos vlassi, alexandra constantinidis, jannis triaridis, stefanos
Purpose: The purpose of this study is to determine the magnitude of change that is clinically meaningful in the EORTC QLQ-C30 and EORTC QLQ-HN35 instruments in head and neck cancer patients. Methods: Two hundred and twenty-two patients completed the EORTC QLQ-C30 and EORTC QLQ-HN35 at baseline and follow-up one to two months later. Minimal clinical...
chiou, ling-jan lin, yun-yen lang, hui-chu
Lung cancer patients suffer from numerous symptoms that impact their quality of life. This study aims to identify the symptom burden on quality of life in lung cancer patients. This survey used a structured questionnaire to collect data from 8 March 2021 to 12 May 2021. Patient demographic information was collected. The data on symptom burden and q...
gliwska, elwira głąbska, dominika zaczek, zuzanna sobocki, jacek guzek, dominika
Background/Objectives: The diminished quality of life experienced by cancer patients impacts not only the individuals but also the broader healthcare system. Despite the effect that cancer has on quality of life both during and after treatment, quality of life assessments are not yet commonly implemented, and the specific factors influencing qualit...
Rugo, Hope S Schmid, Peter Tolaney, Sara M Dalenc, Florence Marmé, Frederik Shi, Ling Verret, Wendy Shah, Anuj Gharaibeh, Mahdi Bardia, Aditya
...
Published in
The oncologist
The TROPiCS-02 study (NCT03901339) demonstrated that sacituzumab govitecan (SG) has superior clinical outcomes over treatment of physician's choice (TPC) chemotherapy in patients with hormone receptor-positive, human epidermal growth factor 2 receptor-negative (HR+/HER2-) metastatic breast cancer (mBC). Here, we present health-related quality of li...
Rugo, Hope Schmid, Peter Tolaney, Sara Dalenc, Florence Marmé, Frederik Shi, Ling Verret, Wendy Shah, Anuj Gharaibeh, Mahdi Bardia, Aditya
...
BACKGROUND: The TROPiCS-02 study (NCT03901339) demonstrated that sacituzumab govitecan (SG) has superior clinical outcomes over treatment of physicians choice (TPC) chemotherapy in patients with hormone receptor-positive, human epidermal growth factor 2 receptor-negative (HR+/HER2-) metastatic breast cancer (mBC). Here, we present health-related qu...
nuñez-vera, victoria garcia-perla-garcia, alberto gonzalez-cardero, eduardo esteban, francisco infante-cossio, pedro
(1) Background: This prospective study aimed to assess the impact on quality of life (QoL) from pretreatment to 3 years after treatment in oropharyngeal carcinoma (OPC) survivors. (2) Methods: QoL was measured with the EORTC QLQ-C30 and EORTC QLQ-H&N35 scales before treatment and in the first and third years. (3) Results: Of 72 patients, 51 complet...
Gudhoor, Manjula Mathew, Aneetta Thankam Ganachari, Akul Madiwalayya Baiju, Gayathri Kulkarni, Sushrut Sachchidanand Ganachari, M S
Published in
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
In this new era of cancer management, the quality of life (QOL) is given more importance than the quantity of life. QOL evaluation studies are widely used in oncology to assess the patient's performance in different cancer types and treatment modalities. To evaluate cancer patients' QOL after various chemotherapy cycles. An observational study was ...
Xu, Richard Huan Wong, Eliza Lai-Yi Luo, Nan Norman, Richard Lehmann, Jens Holzner, Bernhard King, Madeleine T Kemmler, Georg
Published in
The European journal of health economics : HEPAC : health economics in prevention and care
The EORTC QLU-C10D is a new preference-based measure derived from the EORTC QLQ-C30. Country-specific value sets are required to support the cost-utility analysis of cancer-related interventions. This study aimed to generate an EORTC QLU-C10 value set for Hong Kong (HK). A HK online panel was quota-sampled to achieve an adult general population sam...
kiafi, panagiota kouri, maria anthi patatoukas, georgios kougioumtzopoulou, andromachi chalkia, marina nicolatou-galitis, ourania kouloulias, vassilis kyrodimos, efthimios platoni, kalliopi
(1) Background: Head and neck cancer treatment, including advanced techniques like Volumetric Modulated Arc Therapy (VMAT), presents challenges for maintaining patient quality of life (QoL). Thus, thoroughly investigating how radiation therapy (RT) affects patients has been proved essential. Derived by that, this study aims to understand the comple...
Martin, Thomas G.; Moreau, Philippe; Usmani, Saad Z.; Garfall, Alfred; Mateos, Maria-Victoria; San-Miguel, Jesus F.; Oriol, Albert; Nooka, Ajay K.; Rosinol, Laura; Chari, Ajai;
...
INTRODUCTION: Patients with relapsed or refractory multiple myeloma (RRMM) report significantly lower HRQoL compared with patients with newly diagnosed MM and experience further deterioration in HRQoL with each relapse and subsequent treatment. Therefore, consideration of the impact of treatment on HRQoL in addition to clinical outcomes is vital. P...
